Clinical and bacteriological study of cefdinir(CFDN) in treatment of odontogenic infections.
スポンサーリンク
概要
- 論文の詳細を見る
Cefdinir was administered in a oral dose of 100 mg three times a day to 55 patients with odontogenic infections to investigate the clinical and bacteriological effects. The overall clinical efficacy rate of cefdinir was 89.1 %, 92.7 % (38 of 41 patients) for periodontitis and 83.3% (10 of 12) for pericoronitis.<BR>Of these patients, 5 had diabetes. Cefdinir was effective in 4 patients. The bacteriological effect was obtained as follows : The eradication rates were 84.0% (42 of 50 strains) for oral streptococci, 88.2% (15 of 17) for <I>Peptostreptococci</I>, and 100% (14 of 14) for Gram negative anaerobe bacilli (<I>Prevotella, Porphyromonas, Fusobacterium</I>) . The eradication rates were 83.6% for all the aerobic bacteria and 90.6% for the anaerobic bacteria. The clinical efficacy and bacteriological eradication rate in this study was confirmed to be nearly the same as those obtained when cefdinir was marketed in 1991.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果